JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002676200 on May 24, 2000

J. Biol. Chem., Vol. 275, Issue 33, 25102-25108, August 18, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/33/25102    most recent
M002676200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tjalsma, H.
Right arrow Articles by van Dijl, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tjalsma, H.
Right arrow Articles by van Dijl, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Conserved Serine and Histidine Residues Are Critical for Activity of the ER-type Signal Peptidase SipW of Bacillus subtilis*

Harold TjalsmaDagger §, Axel G. Stöver||**, Adam Driks||, Gerard VenemaDagger , Sierd BronDagger DaggerDagger, and Jan Maarten van DijlDagger DaggerDagger§§

From the Dagger  Department of Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, Kerklaan 30, 9751 NN Haren, The Netherlands and the  Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois 60153

Received for publication, March 29, 2000, and in revised form, May 22, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Type I signal peptidases (SPases) are required for the removal of signal peptides from translocated proteins and, subsequently, release of the mature protein from the trans side of the membrane. Interestingly, prokaryotic (P-type) and endoplasmic reticular (ER-type) SPases are functionally equivalent, but structurally quite different, forming two distinct SPase families that share only few conserved residues. P-type SPases were, so far, exclusively identified in eubacteria and organelles, whereas ER-type SPases were found in the three kingdoms of life. Strikingly, the presence of ER-type SPases appears to be limited to sporulating Gram-positive eubacteria. The present studies were aimed at the identification of potential active site residues of the ER-type SPase SipW of Bacillus subtilis, which is required for processing of the spore-associated protein TasA. Conserved serine, histidine, and aspartic acid residues are critical for SipW activity, suggesting that the ER-type SPases employ a Ser-His-Asp catalytic triad or, alternatively, a Ser-His catalytic dyad. In contrast, the P-type SPases employ a Ser-Lys catalytic dyad (Paetzel, M., Dalbey, R. E., and Strynadka, N. C. J. (1998) Nature 396, 186-190). Notably, catalytic activity of SipW was not only essential for pre-TasA processing, but also for the incorporation of mature TasA into spores.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In recent years, interesting similarities between the process of protein transport across the bacterial plasma membrane and the eukaryotic endoplasmic reticular (ER)1 membrane have been documented. These similarities include the direction of protein transport (i.e. export from the cytoplasm), the targeting signal (i.e. the signal peptide), the signal recognition particle, components of the translocation channel, signal peptidases (SPases), and thiol-disulfide oxidoreductases (for reviews, see Refs. 1-4). Notwithstanding these similarities, significant differences between protein transport across bacterial plasma membranes and the ER membrane do exist. First, protein transport is energized in different ways. Although bacterial protein export requires a cytosolic force-generator (i.e. SecA), and the proton-motive-force (5-7), protein import into the ER lumen is driven by the ribosome (co-translational protein transport; Refs. 8-10), or the lumenal Kar2 protein (post-translational protein transport in yeast; Refs. 11 and 12). Second, as exemplified by the SPases, the similarities between components of the different protein transport machineries are rather weak (see Refs. 1 and 2).

Homologous SPases have been identified in Gram-positive and Gram-negative eubacteria, the inner membrane of yeast mitochondria, the thylakoid membrane of chloroplasts, archaea, and the ER membranes of yeast and higher eukaryotes, such as Homo sapiens (Ref. 1; see Fig. 1). These enzymes, which remove signal peptides from translocated proteins, are required for the release of the mature protein from the trans side of the membrane (for reviews, see Refs. 1 and 13). We have previously shown that SPases can be divided into two distinct subfamilies, denoted P- and ER-type SPases. P-type SPases were exclusively identified in eubacteria, mitochondria, and chloroplasts, whereas ER-type SPases were identified in eukaryotes, archaea, and four sporulating Gram-positive eubacteria, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus anthracis, and Clostridium perfringens (Ref. 14; see Fig. 1). Recent studies have provided strong evidence that the P-type SPases employ a Ser-Lys catalytic dyad (1, 15) In contrast, the catalytic mechanism of the ER-type SPases remains to be elucidated (16).

The observation that B. subtilis contained an ER-type SPase, denoted SipW, was remarkable for two reasons. First, SipW represented the first ER-type SPase identified in a eubacterium. Second, SipW happened to be the fifth chromosomally encoded SPase of B. subtilis (14). In contrast to SipW, the other four SPases of B. subtilis, denoted SipS, SipT, SipU, and SipV, are of the P-type (14, 17, 18). Notably, SipU, SipV, and SipW are of minor importance for the processing of secretory pre-proteins, in contrast to SipS and SipT, which are critical for protein secretion and viability (14, 19). This suggested that SipU, SipV, and SipW might be required for the processing of a specific subset of the approximately 180 predicted pre-proteins of B. subtilis. The latter hypothesis was recently confirmed for SipW, which was shown to be required for the processing of the spore-associated protein TasA, displaying antibacterial activities (20). Consistent with a role in sporulation, the expression of the tasA gene (previously known as cotN; Ref. 14), which is located immediately downstream of the sipW gene, depended on the post-exponential growth phase-specific transcription factors SpoOA and SpoOH (20, 21). Interestingly, TasA was not only incorporated into spores, but also secreted into the growth medium. Similar to TasA, the YqxM pre-protein, which is specified by a gene that is located immediately upstream of the sipW gene, was also processed and secreted in a SipW-dependent manner. In contrast to TasA, mature YqxM was not incorporated into spores (22).

The present studies were aimed at the identification of potential active site residues of SipW. For this purpose, TasA was an ideal reporter because its processing is strongly dependent on the presence of the SipW protein (20, 23). Furthermore, in contrast to YqxM, the precursor and mature forms of TasA can be readily detected in sporulating cells of B. subtilis. Finally, TasA could be used to study the importance of processing by SipW for the incorporation of this protein into spores, as neither TasA nor SipW is required for the sporulation process per se. The results show that conserved Ser, His, and Asp residues are critical for the activity of SipW, and that catalytically active SipW is required for the incorporation of mature TasA into spores.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmids, Bacterial Strains, and Media-- Table I lists the plasmids and bacterial strains used. Tryptone/yeast extract (TY medium) contained Bacto-tryptone (1%), Bacto-yeast extract (0.5%), and NaCl (1%). Minimal medium for B. subtilis was prepared as described by Tjalsma et al. (14). When required, medium for Escherichia coli was supplemented with kanamycin (40 µg/ml); media for B. subtilis were supplemented with kanamycin (10 µg/ml), neomycin (3.5 µg/ml), or chloramphenicol (5 µg/ml).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Plasmids and bacterial strains

DNA Techniques-- Procedures for DNA purification, restriction, ligation, agarose gel electrophoresis, and transformation of E. coli were carried out as described by Sambrook et al. (28). Enzymes were from Roche Molecular Biochemicals. B. subtilis was transformed as described by Tjalsma et al. (14). PCR was carried out with Pwo DNA polymerase (Roche Molecular Biochemicals) as described by van Dijl et al. (29). The BLAST algorithm (30) was used for protein comparisons in GenBankTM.

To construct plasmid pGDL140, carrying the wild-type sipW gene, a PCR with the primers lbw-1 and lbw-2 (Table II) was performed using chromosomal B. subtilis 168 DNA as a template. The amplified fragment was subsequently cleaved with SalI and EcoRI, and ligated into the corresponding sites of pGDL48 (24) in such a way that sipW transcription is driven by the constitutive erythromycin promoter. Site-directed mutations were introduced into plasmid-borne copies of sipW by a two-step PCR approach (29), using lbw-1, lbw-2, and the mutagenic oligonucleotides shown in Table II. Amplified fragments were cleaved with SalI and EcoRI, and ligated into the corresponding sites of pGDL48. The resulting plasmids were named pW-x, where x indicates the position and type of amino acid substitution in the corresponding SipW mutant protein.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Oligonucleotides used for sipW mutagenesis

Fractionation of Sporulating Cells and Trypsin Accessibility Assays-- Protoplasts were prepared from sporulating cells of B. subtilis. To this purpose, cells were resuspended in protoplast buffer (20 mM potassium phosphate, pH 7.5, 15 mM MgCl2, 20% sucrose) and incubated for 30 min in the presence of 0.5 mg/ml lysozyme (37 °C). Next, the protoplasts were collected by centrifugation and resuspended in fresh protoplast buffer. If desired, the protoplast-supernatant, which contains cell wall-associated proteins, was collected and used for SDS-PAGE and Western blotting. The protease accessibility of (membrane-associated) proteins was tested by incubating the protoplasts at 37 °C in the presence of 1 mg/ml trypsin (Sigma) for 30 min. In parallel, protoplasts were incubated without trypsin, or in the presence of trypsin and 1% Triton X-100. To isolate endospores, protoplasts were lysed by incubation for 5 min in protoplast buffer containing 1% Triton X-100. To release proteins from the spore envelope, spores were collected by centrifugation, resuspended in protoplast buffer, and incubated for 30 min in the presence of 1 mg/ml lysozyme (37 °C). Next, the samples were incubated at 37 °C in the presence of 1 mg/ml trypsin (Sigma) and 1% Triton X-100 for 30 min to test the protease sensitivity of spore-associated proteins. All trypsin digestions were terminated by the addition of 1.2 mg/ml trypsin inhibitor (Sigma), before boiling in loading buffer for SDS-PAGE.

Western Blot Analysis and Immunodetection-- To obtain SipW-specific antibodies, the pET32a plasmid (Novagen) was used to fuse part of SipW (residues 25-133; lacking its putative membrane anchors) to a thioredoxin fragment containing a hexahistidine tag. The fusion protein was expressed in E. coli, and purified by metal affinity chromatography using the Talon resin supplied by CLONTECH. Rabbits were immunized with the fusion protein at Eurogentec.

Western blotting was performed as described by Kyhse-Andersen (31). Samples for SDS-PAGE were prepared as described by van Dijl et al. (32). After separation by SDS-PAGE, proteins were transferred to Immobilon PVDF membranes (Millipore Corp.). (Pre-)TasA, SipW, GroEL, beta -lactamase, or SspB-LacZ, were visualized with specific antibodies and horseradish peroxidase anti-rabbit-IgG conjugates (Amersham Pharmacia Biotech).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of Conserved Residues in ER-type SPases of Eukaryotes, Archaea, and Eubacteria-- Thus far, genes for 19 different ER-type SPases have been identified in Gram-positive eubacteria, archaea, and eukaryotes. This allowed a detailed comparison of the deduced amino acid sequences of these enzymes (Fig. 1), which showed that they consist of a highly conserved amino-terminal moiety (Fig. 2A, indicated with ER-C) and a highly variable carboxyl-terminal moiety (Fig. 2A, indicated with ER-V). In some enzymes, the variable moiety contains one or three putative membrane spanning domains (Fig. 2B). The highly conserved moiety contains one amino-terminal membrane anchor (A) and four conserved domains (B-E), which are present in all known P- and ER-type SPases (Fig. 1; see Refs. 1 and 14). Domain B contains the conserved serine residue, which has been shown to be critical for the activity of P-type SPases from E. coli (15, 44), B. subtilis (29), and mitochondria (45). Streches of conserved amino acids resembling domain C of the P-type SPases, which seems to be involved in substrate binding (15) and catalysis (46), can be found twice in ER-type SPases (Fig. 1, domain C and C'). Domain D of the ER-type SPases contains a strictly conserved histidine residue, replacing the strictly conserved lysine residue in domain D of the P-type SPases. Finally, domain E contains two conserved aspartic acid residues, the equivalents of which are involved in salt bridge formation in the P-type SPases (15, 47). Recent observations indicate that these salt bridges are important determinants for the stability of some P-type SPases, such as SipS of B. subtilis (29, 46). Interestingly, domain E of the Sec11 protein of Archeoglobus fulgidus seems to be duplicated (Fig. 1). Taken together, these observations suggest that the conserved residues in domains B-E are required for the catalytic activity and/or stability of the ER-type SPases.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 1.   Conserved domains B-E in ER-type SPases from eubacteria, archaea, and eukaryotes. The comparison includes the amino acid sequences of ER-type SPases from the Gram-positive eubacteria B. subtilis (SipW (Bsu); Ref. 14), B. amyloliquefaciens (SipW (Bam); GenBankTM accession no. AF085497), B. anthracis (SipW (Ban)), and C. perfringens (Spc21 (Cpe); GenBankTM accession no. X86488); the archaea: A. fulgidus (Spc21 (Afu), Sec11 (Afu), Sip1 (Afu), and Sip2 (Afu); GenBankTM loci AF1657, AF1791, AF1655, and AF2078, respectively; Ref. 33), Methanobacterium thermoautotrophicum (Sip (Mth); GenBankTM locus MTH1448; Ref. 34), Methanococcus jannaschii (Sip (Mja), GenBankTM locus MJU67481; Ref. 35), and Pyrococcus horikoshii (Spc (Pho) and Sip (Pho); GenBankTM loci PH0590 and PH0563, respectively; Ref. 36); and the eukaryotes: Saccharomyces cerevisiae (Sec11p (Sce); Ref. 37), Schizosaccharomyces pombe (Sec11p (Spo); GenBankTM accession no. E1313476), Caenorhabditis elegans (Spc18 (Cel); Ref. 38), Canis familiaris (Spc18 (Cfa) and Spc21 (Cfa); Refs. 39 and 40), Rattus norvegicus (Spc18 (Rno); Ref. 41), and H. sapiens (Spc18 (Hsa); GenBankTM accession no. G3641344). Residues are printed in bold when present in at least 10 of the 19 ER-type SPases. Numbers refer to the position of the first amino acid of each boxed region (B-E) in the respective SPases. In the consensus sequence below each domain, uppercase letters indicate residues that are strictly conserved in all known ER-type SPases, and lowercase letters show identity in at least 10 sequences. A number sign (#) indicates conserved hydrophobic residues, and + indicates conserved positively charged residues. Note that domain C is duplicated in the ER-type SPases. Conserved residues of B. subtilis SipW (SipW (Bsu)), which, through site-specific mutagenesis, are replaced by alanine (A) or lysine (K), are indicated below the boxed regions. Residues required for activity (star ) of SipW are indicated above the boxed regions. The consensus sequence of the domains B-E of the P-type SPases, is indicated as described by Dalbey et al. (1).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Conserved and variable regions in ER-type SPases. A, ER-type SPases consist of a well conserved amino-terminal moiety (ER-C) and a variable carboxyl-terminal moiety (ER-V). The amino-terminal moiety comprises a membrane anchor (A) and the highly conserved domains (B-E). Five different types of variable carboxyl-terminal moieties (ER-V) can be identified in the known ER-type SPases, four of which contain either one or three (putative) membrane anchors (indicated with a black box), as predicted with algorithms developed by Sipos and von Heijne (42). Conserved stretches of amino acids in the ER-V moieties are indicated with patterned boxes. B, comparison of the predicted membrane topologies of the ER-type SPases. The orientation of putative transmembrane segments, A(nchor) I-A(nchor) IV, was predicted by the TopPred2 algorithm (42, 43). Domains B-E in the highly conserved amino-terminal moiety are indicated. The highly variable carboxyl-terminal moiety, which may contain one or three transmembrane segments, is indicated with a dotted line. N, amino terminus; C, carboxyl terminus; in, cytoplasmic side of the membrane; out, extracytoplasmic, cell wall-exposed side of the membrane (eubacteria and archaea), or the ER lumen (eukaryotes).

Identification of the Potential Active Site of SipW-- To investigate whether the conserved residues of domains A-E of the ER-type SPases are required for the activity of SipW of B. subtilis, we exploited the recent observation that SipW is of major importance for processing of the spore-associated protein TasA (20). To this purpose, a plasmid-based complementation system was developed, involving B. subtilis strain Delta W-CtasA, which lacks SipW ("Delta W") and constitutively produces pre-TasA ("CtasA"). First, B. subtilis Delta W-CtasA was transformed with pGDL140 ("SipW"; constitutive expression of sipW), pGDL41 ("SipS"; 5-fold overproduction of SipS in the stationary growth phase; data not shown), or pGDL48 ("empty vector"; no SPase overproduction). Next, the effects on the processing of pre-TasA to the mature form were evaluated by growing the resulting strains in TY medium, sampling after 4, 16, and 32 h of post-exponential growth, and Western blotting of total cell and sporangial lysates. The results show that after 4 h of post-exponential growth (t = 4), only pre-TasA was present in cells of B. subtilis Delta W-CtasA, irrespective of the (over)production of SipS or SipW (Fig. 3A). The observation that the presence of multiple copies of sipW did not stimulate pre-TasA processing at t = 4 suggests that SipW requires an as yet unidentified partner protein that is not (yet) expressed at this time. In contrast, after 16 h of post-exponential growth (t = 16), B. subtilis Delta W-CtasA cells producing SipW contained both the precursor and mature forms of TasA, whereas no mature TasA was observed in B. subtilis Delta W-CtasA cells lacking SipW (Fig. 3A). Finally, after 32 h (t = 32), most TasA molecules in B. subtilis Delta W-CtasA cells producing SipW were mature. In contrast, significantly lower amounts of mature TasA were detectable in B. subtilis Delta W-CtasA cells lacking SipW (Fig. 3A). The SipW-independent processing of pre-TasA at t = 32 was not affected by SipS overproduction, suggesting that one or more other SPases are responsible for this effect. As no SipW-independent processing of pre-TasA was observed at t = 16, this time point was selected to monitor the activity of SipW proteins with site-specific mutations.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   SipW-dependent processing of pre-TasA. A, pre-TasA processing in B. subtilis Delta W-CtasA, transformed with pGDL140 (SipW), pGDL41 (approximately 5-fold overproduction of SipS; data not shown), or pGDL48 (empty vector) was analyzed by SDS-PAGE, Western blotting, and immunodetection with TasA-specific antibodies. Upon 4, 16, and 32 h of post-exponential growth in TY medium, cells were collected by centrifugation and used for SDS-PAGE (zero time (t = 0) defines the transition point between the exponential and post-exponential growth phases). The positions of precursor (p) and mature (m) forms of TasA are indicated. B, pre-TasA processing by SipW mutant proteins. B. subtilis Delta W-CtasA was transformed with plasmids pW-S47A, pW-H87A, pW-R88A, pW-K104A, pW-D106A, or pW-D112A, all of which specify a SipW mutant protein. Pre-TasA processing in these strains, and B. subtilis Delta W-CtasA harboring pGDL140 (SipW; positive control), or pGDL41 (SipS; negative control), was monitored after 16 h of post-exponential growth in TY medium as described in panel A of this figure. C, the integrity of SipW mutant proteins with strongly reduced activity was analyzed by SDS-PAGE, Western blotting, and immunodetection with SipW-specific antibodies. Samples were taken of B. subtilis Delta W-CtasA cells harboring the plasmids pW-S47A, pW-H87A, pW-D106A, pGDL140 (SipW), or pGDL41 (SipS; negative control) after 16 h of post-exponential growth in TY medium. The presence of sipW-containing plasmids, which also contain a gene encoding beta -lactamase, was monitored with beta -lactamase-specific antibodies. The positions of SipW-specific and beta -lactamase-specific (Bla) bands are indicated. D, pre-TasA processing by SipW-H87K was analyzed by using B. subtilis Delta W-CtasA transformed with the plasmids pW-H87K, or pW-H87A (negative control) as described in panel B of this figure.

To investigate the importance for pre-TasA processing of conserved residues in domains B-E of SipW, the residues Ser-47, His-87, Arg-88, Lys-104, Asp-106, or Asp-112 were replaced by alanine (see Fig. 1; note that the latter residue numbers correspond to the sequence of SipW of B. subtilis (Bsu)). Alanine was chosen because it is small, and has a chemically inert side chain, minimizing conformational strain and indirect effects on catalysis. To monitor pre-TasA processing by the various SipW mutant proteins, B. subtilis Delta W-CtasA was transformed with plasmids encoding wild-type SipW (positive control), the SipW mutant proteins S47A, H87A, R88A, K104A, D106A, or D112A, or SipS (negative control). The resulting strains were grown in TY medium until t = 16. As demonstrated by Western blotting, more than 50% of the TasA molecules in cells producing SipW-R88A, -K104A, or -D112A was in the mature form, similar to cells producing wild-type SipW (Fig. 3B), showing that Arg-88, Lys-104, and Asp-112 are not important for pre-TasA processing. In contrast, very low amounts of mature TasA were detectable in cells producing SipW-D106A. No mature TasA was detectable in cells producing SipW-S47A or -H87A, as in SipS-producing cells. These results show that the conserved serine and histidine residues of SipW are critical for the processing of pre-TasA, and that Asp-106 is very important for this activity. Notably, the conserved His-87 of SipW could be replaced by lysine without loss of pre-TasA processing (Fig. 3D), suggesting that a basic residue at this position is required for activity of SipW.

Unexpectedly, only the completely inactive SipW-S47A and -H87A mutant proteins reacted (weakly) with a SipW-specific antibody, whereas neither wild-type SipW nor the active SipW mutant proteins, including SipW-D106A, were detectable (Fig. 3C, upper panel). This weak interaction, or the complete absence of reactivity between SipW (mutant proteins) and SipW-specific antibodies was not due to a loss of sipW-containing plasmids, as shown by the detection of comparable amounts of the plasmid-encoded beta -lactamase in all samples (Fig. 3C, lower panel). The latter observations suggest that the catalytically active forms of SipW are subject to self-cleavage, as described previously for the purified SPase of E. coli (49). In summary, these results suggest that Ser-47 and His-87 are involved in catalysis, and that Asp-106 is either involved in catalysis or in maintaining a stable conformation.

Catalytic Activity of SipW Is Required for TasA Incorporation into Spores-- To investigate the importance of SipW for TasA incorporation into spores, fractionation experiments were performed (schematically presented in Fig. 4A), in which the cytosolic GroEL protein was used as a reference marker for protoplast integrity and, upon permeabilization of membranes with Triton X-100, trypsin activity. As shown with B. subtilis Delta W-CtasA (pGDL140), at t = 32, TasA has a dual localization in sporulating cells producing SipW. First, a significant fraction of the mature TasA could be released from these cells by protoplasting, showing that these molecules were present in the cell wall (Fig. 4B). Second, pre-TasA remained protoplast-associated, but was degraded when trypsin was added to the protoplasts, showing that this form of TasA accumulated at the membrane-cell wall interface. Third, significant amounts of mature TasA remained associated with the protoplasts in a trypsin-resistant form. The latter TasA molecules were not degraded by trypsin when the protoplasts were lysed with Triton X-100. In fact, these molecules were associated with spores, and they only became accessible to trypsin upon incubation of isolated spores with lysozyme and Triton X-100 (Fig. 4A; note that lysozyme and Triton X-100 were sufficient to cause spore lysis due to the absence of a spore coat in B. subtilis Delta W-CtasA). In contrast, all mature TasA produced by B. subtilis Delta W-CtasA (pGDL41), which lacks SipW, was released from the sporulating cells by protoplasting, showing that it was localized in the cell wall of the mother cell and not in spores (Fig. 4C). Similar to SipW-producing cells, the pre-TasA molecules accumulating in cells lacking SipW were protoplast-associated and, upon protoplasting, accessible to trypsin, indicating that they were localized at the membrane-cell wall interface of the mother cell. In addition, a specific 29-kDa degradation product of TasA (d), which accumulates in the absence of SipW, was localized at the membrane-cell wall interface.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   SipW is essential for incorporation of mature TasA into spores. To determine the localization of precursor and mature forms of TasA in sporulating cells of B. subtilis, fractionation experiments were performed as schematically presented in panel A. The cell wall (w) is indicated in gray shading. Solid lines indicate intact membranes, and dotted lines indicate membranes disrupted with Triton X-100. Note that endospores are initially surrounded by two membranes (see Ref. 48). C, intact cell; PP, protoplast; SP, spore; T, trypsin. B-D, cells of B. subtilis Delta W-CtasA harboring the plasmids pGDL140 (SipW; panel B) or pGDL41 (no SipW; panel C), or cells of B. subtilis PM8 (SspB-LacZ; panel D) were grown in TY medium until 32 h after the transition between exponential and post-exponential growth. Next, cells (c) were protoplasted, and protoplasts (pp) were separated from the cell wall (w) fraction (i.e. protoplast supernatant) by centrifugation. Complete cells, protoplasts, and the cell wall fraction were used for SDS-PAGE, Western blotting, and immunodetection with TasA-, GroEL-, or LacZ-specific antibodies. In addition, protoplasts were incubated for 30 min in the presence of trypsin (1 mg/ml), or trypsin plus Triton X-100 (1%). Finally, endospores (sp) were isolated from the lysed cells to investigate whether spore-associated TasA was trypsin resistant per se, or protected against trypsin by the spore envelope. Spores were incubated with lysozyme prior to the addition of trypsin plus Triton X-100. Intact and lysed spores were used for SDS-PAGE and Western blotting. The positions of GroEL (cytosolic marker), SspB-LacZ (spore-specific marker), and pre-TasA (p), mature TasA (m), and a degradation (d) product of TasA are indicated.

To verify whether the above fractionation experiments truly reflected the situation in sporulating cells that are wild-type with respect to the temporally controlled synthesis of TasA and SipW, similar fractionation experiments were performed with B. subtilis PM8. This strain offers the advantage that it produces the E. coli beta -galactosidase (LacZ) exclusively in the forespore (26, 27). Thus, the fractionation of spore-associated proteins can be monitored with antibodies against LacZ. This was not possible with antibodies against GroEL as this protein appears to be absent from spores (Fig. 4, B and C). As shown in Fig. 4D, B. subtilis PM8 showed similar fractionation patterns for TasA and GroEL as B. subtilis Delta W-CtasA (pGDL140) (Fig. 4B). Furthermore, LacZ cofractionated with spores. Notably, a significant fraction of the LacZ molecules appeared to be trypsin-sensitive upon protoplast lysis, indicating that the spores were not yet mature.

To determine whether active SipW is required for the sorting of TasA to spores, fractionation experiments were performed with B. subtilis Delta W-CtasA producing SipW mutant proteins. As shown in Fig. 5, trypsin-resistant mature TasA was absent from protoplasts of B. subtilis Delta W-CtasA producing the S47A or H87A SipW mutant proteins. In contrast, trypsin-resistant mature TasA was present in protoplasts of B. subtilis Delta W-CtasA producing the H87K, R88A, K104A, D106A, or D112A SipW mutant proteins, or wild-type SipW. Irrespective of the presence of active or inactive mutant SipW proteins, the pre-TasA accumulating in protoplasts of B. subtilis Delta W-CtasA was accessible to trypsin (Fig. 5).


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 5.   Catalytically active SipW is required for TasA incorporation into spores. To determine the localization of precursor and mature forms of TasA in sporulating cells carrying mutant SipW proteins, B. subtilis Delta W-CtasA harboring the plasmids pW-S47A, pW-H87A, pW-R88A, pW-K104A, pWD106A, pW-D112A, pGDL41 (no SipW; negative control), or pGDL140 (SipW; positive control) were grown in TY medium for 32 h after the transition between exponential and post-exponential growth. Subsequently, cells were protoplasted and incubated for 30 min without further additions, in the presence of trypsin (1 mg/ml), or in the presence of trypsin plus Triton X-100 (1%). Samples were used for SDS-PAGE, Western blotting, and immunodetection with TasA- and GroEL-specific antibodies (cytoplasmic control). The positions of pre-TasA (p), mature TasA (m), and GroEL are indicated.

In summary, these observations show that active SipW is required for the incorporation of mature TasA into spores, but not for the accumulation of mature TasA in the cell wall of sporulating cells.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present studies, we document the importance of SipW for processing of pre-TasA and incorporation of mature TasA into spores. Translocated pre-TasA was almost exclusively processed by SipW, a process that requires three conserved residues (i.e. Ser-47, His-87, and Asp-106) of this SPase. In sporulating cells lacking active SipW, TasA did not reach the spores. Instead, TasA precursors were translocated across and remained attached to the cytoplasmic membrane, most likely with their uncleaved signal peptides. Upon prolonged growth in the absence of SipW, pre-TasA was processed by other, yet unidentified, SPases of B. subtilis. Most likely, this alternative pre-TasA processing is a result of the combined activities of SipS, SipT, SipU, and/or SipV, as the SPases of B. subtilis, including SipW, have overlapping substrate specificities (14, 18). Strikingly, mature TasA produced by alternative processing in the absence of SipW did not reach the spores, but remained associated with the cell wall. This shows that the presence of SipW is a prerequisite for the incorporation of mature TasA into spores. Interestingly, this process requires active SipW and cannot be promoted by catalytically inactive SipW molecules. It is presently not clear how SipW functions as a determinant for the incorporation of TasA into spores, or why alternatively processed mature TasA is not incorporated into spores.

As recently confirmed by the crystal structure of a catalytically active soluble fragment of the E. coli SPase I (15), also known as leader peptidase, P-type SPases employ a Ser-Lys catalytic dyad, similar to LexA-like proteases (29, 45, 50-52). The observations that the catalytic serine residue of the P-type SPases is well conserved in the ER-type SPases, and that this conserved serine residue (Ser-47) is essential for the activity of SipW, indicate that the ER-type SPases employ a serine residue for catalysis. Notably, the ER-type SPases contain a strictly conserved histidine residue instead of the catalytic lysine residue of the P-type SPases (17, 53). This conserved histidine residue (His-87) is essential for activity of SipW. Taken together, these findings suggest that Ser-47 of SipW acts as a nucleophile that attacks the carbonyl carbon of the scissile peptide bond, whereas His-87 acts as a general base by stripping the proton from the hydroxyl group of the serine side chain. A similar role has been proposed for the corresponding serine and histidine residues of Sec11p from yeast (16). The role of the strictly conserved Asp-106 residue of SipW, which is important, but not essential, for activity, is less clear. First, by analogy to the classical serine proteases, Asp-106 could form a catalytic triad together with Ser-47 and His-87, thereby serving to keep the side chain of His-87 deprotonated. Second, Asp-106 could be a determinant for the stability of SipW, as described previously for Asp-146 of SipS of B. subtilis (14, 29) and Asp-103 of Sec11p (16). The latter hypothesis is supported by the observation that both aspartic acid residues are present at equivalent positions in the conserved domain E of P- and ER-type SPases. Furthermore, the recent observation that the equivalent Asp residue in domain E of the SPase I of E. coli is not required for activity (49) suggests that this conserved Asp residue has a structural rather than a catalytic function. Thus, it is possible that ER-type SPases, such as SipW, employ a Ser-His catalytic dyad, instead of the Ser-His-Asp catalytic triad of the classical serine proteases. The latter view is strongly supported by the observation that the potential active site His-47 residue of SipW can be replaced by lysine without loss of pre-TasA processing activity. This implies that the catalytic mechanisms of P-type SPases and ER-type SPases are, at least to some extent, related.

    ACKNOWLEDGEMENTS

We thank Drs. A. Bolhuis, J. D. H. Jongbloed, M. L. van Roosmalen, and other members of the European Bacillus Secretion Group for useful discussions.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by Genencor International (Rijswijk, The Netherlands) and Gist-brocades B.V. (Delft, The Netherlands).

|| Supported by Public Health Service Grant GM539898 from the National Institutes of Health and a grant from the Schweppe Foundation.

** Supported in part by a Schmitt fellowship.

Dagger Dagger Supported by Biotechnology Grants Bio4-CT95-0278 and Bio4-CT96-0097 and "Quality of Life and Management of Living Resources" Grants QLK3-CT-1999-00415 and QLK3-CT-1999-00917 from the European Union.

§§ To whom correspondence should be addressed. Present address: Dept. of Pharmaceutical Biology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. Tel.: 31-503633079; Fax: 31-503632348; E-mail: j.m.van.dijl@farm.rug.nl.

Published, JBC Papers in Press, May 24, 2000, DOI 10.1074/jbc.M002676200

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticular; SPase, signal peptidase; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; TY, tryptone/yeast extract; P-type, prokaryotic.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Dalbey, R. E., Lively, M. O., Bron, S., and van Dijl, J. M. (1997) Protein Sci. 6, 1129-1138
2. Pohlschröder, M., Prinz, W. A., Hartmann, E., and Beckwith, J. (1997) Cell 91, 563-566
3. von Heijne, G. (1990) Curr. Opin. Cell Biol. 2, 604-608
4. von Heijne, G. (1998) Nature 396, 111, 113
5. den Blaauwen, T., and Driessen, A. J. M. (1996) Arch. Microbiol. 165, 1-8
6. Wickner, W., and Leonard, M. R. (1996) J. Biol. Chem. 271, 29514-29516
7. Economou, A. (1998) Mol. Microbiol. 27, 511-518
8. Görlich, D., and Rapoport, T. A. (1993) Cell 75, 615-630
9. Crowley, K. S., Liao, S., Worrell, V. E., Reinhart, G. D., and Johnson, A. E. (1994) Cell 78, 461-471
10. Riezman, H. (1997) Science 278, 1728-1729
11. Brodsky, J. L., Goeckeler, J., and Schekman, R. W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9643-9646
12. Panzner, S., Dreier, L., Hartmann, E., Kostka, S., and Rapoport, T. A. (1995) Cell 81, 561-570
13. Pugsley, A. P. (1993) Microbiol. Rev. 57, 50-108
14. Tjalsma, H., Bolhuis, A., van Roosmalen, M. L., Wiegert, T., Schumann, W., Broekhuizen, C. P., Quax, W. J., Venema, G., Bron, S., and van Dijl, J. M. (1998) Genes Dev. 12, 2318-2331
15. Paetzel, M., Dalbey, R. E., and Strynadka, N. C. J. (1998) Nature 396, 186-190
16. VanValkenburg, C., Xuemin, C., Mullins, C., Fang, H., and Green, N. (1999) J. Biol. Chem. 274, 11519-11525
17. van Dijl, J. M., de Jong, A., Vehmaanper, J., Venema, G., and Bron, S. (1992) EMBO J. 11, 2819-2828
18. Tjalsma, H., Noback, M. A., Bron, S., Venema, G., Yamane, K., and van Dijl, J. M. (1997) J. Biol. Chem. 272, 25983-25992
19. Tjalsma, H., van den Dolder, J., Meijer, W. J. J., Venema, G., Bron, S., and van Dijl, J. M. (1999) J. Bacteriol. 181, 2448-2454
20. Stöver, A. G., and Driks, A. (1999) J. Bacteriol. 181, 1664-1672
21. Stöver, A. G., and Driks, A. (1999) J. Bacteriol. 181, 5476-5481
22. Stöver, A. G., and Driks, A. (1999) J. Bacteriol. 181, 7065-7069
23. Serrano, M., Zilhao, R., Ricca, E., Ozin, A. J., Moran, C. P., Jr., and Henriques, A. O. (1999) J. Bacteriol. 181, 3632-3643
24. Meijer, W. J. J., de Jong, A., Wisman, G. B. A., Tjalsma, H., Venema, G., Bron, S., and van Dijl, J. M. (1995) Mol. Microbiol. 17, 621-631
25. Wertman, K. F., Wyman, A. R., and Botstein, D. (1986) Gene (Amst.) 49, 253-262
26. Mason, J. M., Hackett, R. H., and Setlow, P. (1988) J. Bacteriol. 170, 239-244
27. Margolis, P., Driks, A., and Losick, R. (1991) Science 254, 562-565
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. van Dijl, J. M., de Jong, A., Venema, G., and Bron, S. (1995) J. Biol. Chem. 270, 3611-3618
30. Altschul, S. F., Madden, T. L., Schaffer, A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402
31. Kyhse-Andersen, J. (1984) J. Biochem. Biophys. Methods 10, 203-209
32. van Dijl, J. M., de Jong, A., Smith, H., Bron, S., and Venema, G. (1991) Mol. Gen. Genet. 227, 40-48
33. Klenk, H. P., Clayton, R. A., Tomb, J. F., White, O., Nelson, K. E., Ketchum, K. A., Dodson, R. J., Gwinn, M., Hickey, E. K., Peterson, J. D., Richardson, D. L., et al.. (1997) Nature 390, 364-370
34. Smith, D. R., Doucette-Stamm, L. A, Deloughery, C., Lee, H., Dubois, J., Aldredge, T., Bashirzadeh, R., Blakely, D., Cook, R., Gilbert, K., et al.. (1997) J. Bacteriol. 179, 7135-7155
35. Bult, C. J., White, O., Olsen, G. J., Zhou, L., Fleischmann, R. D., Sutton, G. G., Blake, J. A., FitzGerald, L. M., Clayton, R. A., Gocayne, J. D., Kerlavage, A. R., Dougherty, B. A., Tomb, J. F., Adams, M. D., Reich, C. I., Overbeek, R., Kirkness, E. F., Weinstock, K. G., Merrick, J. M., Glodek, A., Scott, J. L., Geoghagen, N. S. M., and Venter, J. C. (1996) Science 273, 1058-1073
36. Kawarabayasi, Y., Sawada, M., Horikawa, H., Haikawa, Y., Hino, Y., Yamamoto, S., Sekine, M., Baba, S., Kosugi, H., Hosoyama, A., Nagai, Y., Sakai, M., Ogura, K., Otsuka, R., Nakazawa, H., Takamiya, M., Ohfuku, Y., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., and Kikuchi, H. (1998) DNA Res. 5, 147-155
37. Böhni, P. C., Deshaies, R. J., and Schekman, R. W. (1988) J. Cell Biol. 106, 1035-1042
38. The C. elegans Sequencing Consortium. (1998) Science 282, 2012-2018
39. Shelness, G. S., Lin, L., and Nicchitta, C. V. (1993) J. Biol. Chem. 268, 5201-5208
40. Greenburg, G., Shelness, G. S., and Blobel, G. (1989) J. Biol. Chem. 264, 15762-15765
41. Signs, S. A., and Jacquet, R. (1994) Mol. Cell. Biochem. 139, 21-26
42. Sipos, L., and von Heijne, G. (1993) Eur. J. Biochem. 213, 1333-1340
43. von Heijne, G. (1992) J. Mol. Biol. 225, 487-494
44. Tschantz, W. R., Sung, M., Delgado-Partin, V. M., and Dalbey, R. E. (1993) J. Biol. Chem. 268, 27349-27354
45. Nunnari, J., Fox, T. D., and Walter, P. (1993) Science 262, 1997-2004
46. Bolhuis, A., Tjalsma, H., Stephenson, K., Harwood, C. R., Venema, G., Bron, S., and van Dijl, J. M. (1999) J. Biol. Chem. 274, 15865-15868
47. Klenotic, P. A., Carlos, J. L., Samuelson, J. C., Schuenemann, T. A., Tschantz, W. R., Paetzel, M., Strynadka, N. C. J., and Dalbey, R. E. (2000) J. Biol. Chem. 275, 6490-6498
48. Stragier, P., and Losick, R. (1996) Annu. Rev. Genet. 30, 297-241
49. Talarico, T. L., Dev, I. K., Bassford, P. J., and Ray, P. H. (1991) Biochem. Biophys. Res. Commun. 181, 650-656
50. Lin, L. L., and Little, J. W. (1989) J. Mol. Biol. 210, 439-452
51. Black, M. T. (1993) J. Bacteriol. 175, 4957-4961
52. Little, J. W. (1993) J. Bacteriol. 175, 4943-4950
53. Dalbey, R. E., and von Heijne, G. (1992) Trends Biochem. Sci. 17, 474-478


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
D. Zahner and J. R. Scott
SipA Is Required for Pilus Formation in Streptococcus pyogenes Serotype M3
J. Bacteriol., January 15, 2008; 190(2): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. Y. M. Ng, B. Chaban, D. J. VanDyke, and K. F. Jarrell
Archaeal signal peptidases
Microbiology, February 1, 2007; 153(2): 305 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
A. Fine, V. Irihimovitch, I. Dahan, Z. Konrad, and J. Eichler
Cloning, Expression, and Purification of Functional Sec11a and Sec11b, Type I Signal Peptidases of the Archaeon Haloferax volcanii.
J. Bacteriol., March 1, 2006; 188(5): 1911 - 1919.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. L. Bardy, S. Y. M. Ng, D. S. Carnegie, and K. F. Jarrell
Site-Directed Mutagenesis Analysis of Amino Acids Critical for Activity of the Type I Signal Peptidase of the Archaeon Methanococcus voltae
J. Bacteriol., February 1, 2005; 187(3): 1188 - 1191.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
E Scala, F Ariani, F Mari, R Caselli, C Pescucci, I Longo, I Meloni, D Giachino, M Bruttini, G Hayek, et al.
CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms
J. Med. Genet., February 1, 2005; 42(2): 103 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. Imamura, K. Kobayashi, J. Sekiguchi, N. Ogasawara, M. Takeuchi, and T. Sato
spoIVH (ykvV), a Requisite Cortex Formation Gene, Is Expressed in Both Sporulating Compartments of Bacillus subtilis
J. Bacteriol., August 15, 2004; 186(16): 5450 - 5459.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. S. Branda, J. E. Gonzalez-Pastor, E. Dervyn, S. D. Ehrlich, R. Losick, and R. Kolter
Genes Involved in Formation of Structured Multicellular Communities by Bacillus subtilis
J. Bacteriol., June 15, 2004; 186(12): 3970 - 3979.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Tjalsma, H. Antelmann, J. D.H. Jongbloed, P. G. Braun, E. Darmon, R. Dorenbos, J.-Y. F. Dubois, H. Westers, G. Zanen, W. J. Quax, et al.
Proteomics of Protein Secretion by Bacillus subtilis: Separating the "Secrets" of the Secretome
Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 207 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. Stephenson, C. Mueller, M. Jiang, and M. Perego
Molecular Analysis of Phr Peptide Processing in Bacillus subtilis
J. Bacteriol., August 15, 2003; 185(16): 4861 - 4871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tjalsma, S. Bron, and J. M. van Dijl
Complementary Impact of Paralogous Oxa1-like Proteins of Bacillus subtilis on Post-translocational Stages in Protein Secretion
J. Biol. Chem., April 25, 2003; 278(18): 15622 - 15632.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Tjalsma, A. Bolhuis, J. D. H. Jongbloed, S. Bron, and J. M. van Dijl
Signal Peptide-Dependent Protein Transport in Bacillus subtilis: a Genome-Based Survey of the Secretome
Microbiol. Mol. Biol. Rev., September 1, 2000; 64(3): 515 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. van Roosmalen, J. D. H. Jongbloed, J.-Y. F. Dubois, G. Venema, S. Bron, and J. M. van Dijl
Distinction between Major and Minor Bacillus Signal Peptidases Based on Phylogenetic and Structural Criteria
J. Biol. Chem., June 29, 2001; 276(27): 25230 - 25235.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/33/25102    most recent
M002676200v1
Right arrow Alert me when this article is cited